Pinned Tweet
If $KSPI said they were expanding to my country, best thing to do would be to move.
Why wasn't Kaspi able to go international after being so successful while being surrounded by similar markets?
Kazakh's market is saturated and they can only expand adding new verticals 🧵
Si $CBAV sigue bajando y lo de UK sigue por el buen camino, puede que pronto se pueda volver a comprar.
Lleva bastante tiempo algo caro y es una lástima porque me gustaría seguir ampliando.
In relation to my prior posts and to be fair internationalisation is often hard, even when the business itself is simple and you don’t need a decade of licences to open the next site.
Take $CBAV. In Spain since 1992, Germany and Italy since 2008, UK since 2024.
Spain still generates 81% of the EBITDA. That would be normal if it was only a matter of having more clinics. But in H1 EBITDA/clinic:
- each Spanish clinic produced about €450k of EBITDA
- €260k in Germany
- €190k in Italy
- UK ones still lose money
The thesis is the same everywhere: ageing population, more eye problems, public healthcare covering less and getting slower...
So why does Spain work so much better?
4
213
I'll be afk 1 month roaming arround Japan.
Take good care of the stock market in my absence.
1
1
202
$FRPH es el ejemplo paradigmático de una acción cuya narrativa cambia simplemente porque el precio no sube.
De un día a otro, un equipo que era considerado de los mejores y velar por el minoritario, pasa a ser criticado y se les pide que reparta capital.
Aquí no hace falta ni leerse los quarters, sólo ser paciente (muy paciente).
2
295
You might not like the company or its numbers.
But you have to recognize that $HIMS is the pump and dump king.
2
337
This $NVDA drama is a very good opportunity.
Not for buying the stock, but to curate X's timeline.
1
129
Hepsiburada results were dog shit.
Hard to know if it's necessary pain during the transition or that $KSPI is not really capable of pulling a proper international expansion.
We will find out together.
If $KSPI said they were expanding to my country, best thing to do would be to move.
Why wasn't Kaspi able to go international after being so successful while being surrounded by similar markets?
Kazakh's market is saturated and they can only expand adding new verticals 🧵
6
25
3,485
Abro posición en $MELI
Oficialmente me he convertido en un growth/quality bro
135
Ditto Money retweeted
Cannabis earnings season is exposing huge multiple gaps. $VFF trades ~4.5x ‘27 EBITDA while $OGI pays 11.3x for $ACB, largely for its EU GMP moat.
$VFF has one of the biggest EU GMP footprints anywhere. With strong optionality in Texas.
$CRON posting another strong quarter says fundamentals are back in focus.
To me, $VFF $7 looks very reasonable; Texas progress could open $10+
Añado a $FRPH a 17,8$
1
403
Ditto Money retweeted
“I’m not going to legalize marijuana in Texas. And if people want to vote me out of office for that, so be it,” declared Texas Lieutenant Governor Dan Patrick. Well, you got what you asked for.
Imaginad como de mal está la industria de la automoción...
$BMW presenta por debajo de estimaciones, en la presentación hay perlas como esta y la acción sube un 4%.
2
208
Nice close for $VFF
And this is just the beginning. ER in 1 week!!
This is my quant
You can tell a lot about a company by the physiognomy of their CEO:
1. Yoni Assia, $ETOR
- Subject exhibits a remarkably auspicious physiognomy, marked by rounded jovial countenance, full cheeks, and a broad radiant smile. According to classical theorists, such features denote exceptional benevolence, intellectual acuity, sound judgement, and an inherently trustworthy disposition.
2. Brian Armstrong, $COIN
- Subject exhibits markedly hairless cranium, deeply recessed dark eyes and thin compressed lips as hallmarks of the Austere Capital Extraction Phenotype. Purported signs include diminished benevolence, an apparent absence of soul, and a rigid, labial compression allegedly indicating a profound deficiency in shareholder empathy and an elevated propensity for capital misappropriation.
3. Vlad Tenev, $HOOD
- Subject exhibits small, beady dark eyes, almost vampiric pallor, no smile and an unsettling, impassive aura. The absence of crow’s feet is read as evidence of suppressed benevolence, while the unyielding gaze becomes the Nocturnal Capital Extraction Phenotype.
4. Wang Anquan, $BULL
- Subject exhibits a flattened facial profile, receding frontal hairline, and tiny ragged teeth resembling incisors worn down by relentless gnawing. In the discipline of pathological financial physiognomy, this forms the Yellow Skinned Coward CCP Phenotype, which is said to signal an ominous appetite for shareholder wealth.
1
1
574





















